Destined Rivals · 231 · Special Illustration Rare · 2025
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
Premium19 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶PSA 10 | $1,229 $898–$3,500 from sold comps | 3.1× | 16,798 | 0 |
| ▶PSA 9 | $504 $355–$675 from sold comps | 1.3× | 8,747 | 16,798 |
| ▶PSA 8.5 | $448 $425–$525 | 1.1× | 43 | 25,545 |
| ▶PSA 8 | $466 $310–$677 | 1.2× | 2,554 | 25,588 |
| ▶PSA 7 | $454 $380–$500 | 1.1× | 783 | 28,145 |
| ▶PSA 6 | $412 | 1.0× | 187 | 28,928 |
| ▶PSA 5 | $410 | 1.0× | 50 | 29,115 |
| ▶PSA 4 | $330 | 0.8× | 16 | 29,165 |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶BGS 10blended | $2,107 $1,300–$13,600 | 5.3× | — | — |
| ▶BGS 9.5 | $812 $535–$1,200 | 2.0× | — | — |
| ▶BGS 9 | $517 $400–$750 | 1.3× | — | — |
| ▶BGS 8.5 | $515 $386–$539 | 1.3× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| ▶CGC 10 | $852 $466–$1,750 from sold comps | 2.1× | — | — |
| ▶CGC 9.5 | $471 $400–$650 | 1.2× | — | — |
| ▶CGC 9 | $445 $395–$525 | 1.1× | — | — |
| ▶CGC 8.5 | $478 | 1.2× | — | — |
| ▶CGC 8 | $450 | 1.1× | — | — |
| ▶CGC 7.5 | $468 | 1.2× | — | — |
| ▶CGC 6.5 | $437 | 1.1× | — | — |
A model's opinion, not investment advice.